Drug Abuse Warning Network (DAWN): ED Visits Involving Alcohol Short Report presents the following data from January 2021-September 2023 (1) national estimates and characteristics of alcohol-related ED visits (2) demographics of alcohol-related ED visits (3) percent of ED visits related to alcohol and at least one other substance.
Dashboard: Filter Bricks
Main page content
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep24-07-019-thumb.png?itok=z3BAm9H3)
![Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets](/sites/default/files/styles/product_thumbnail_dashboard/public/pep20-03-02-001.png?itok=WqnHUycy)
The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).
![Key Substance Use and Mental Health Indicators in the United States:Results from the 2016 National Survey on Drug Use and Health (NSDUH)](/sites/default/files/styles/product_thumbnail_dashboard/public/sma17-5044.jpg?itok=MaU_FmHQ)
This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented.
![Results from the 2014 National Survey on Drug Use and Health: Summary of National Findings](/sites/default/files/styles/product_thumbnail_dashboard/public/sma15-4927.jpg?itok=H-mkecOB)
This NSDUH report discusses trends in the prevalence of mental illness, substance use disorders, or both among adolescents and adults in the United States.
![Quick Guide for Counselors Based on TIP 49](/sites/default/files/styles/product_thumbnail_dashboard/public/sma10-4542.jpg?itok=Wwqu2P7W)
This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.